Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach
Shengyu Fang(Capital Medical University), Lei Wang(Capital Medical University), Shaowu Li(Capital Medical University), Tao Jiang(Beijing Tian Tan Hospital), Yiming Li(Tianjin Medical University General Hospital), Xing Liu(Capital Medical University), Hong Zhang(Columbia University), Yukun Liu(Harvard University), Yinyan Wang(Chinese Academy of Sciences), Zhiyan Sun(Tongji University), Yuchao Liang(Capital Medical University), Qiang Zhu(Capital Medical University), Chunyao Zhou(Capital Medical University), Tianshi Li(Capital Medical University), Ziwen Fan(Capital Medical University)
Cited by 22
Related Papers
RNA-seq of 272 gliomas revealed a novel, recurrent <i>PTPRZ1-MET</i> fusion transcript in secondary glioblastomas
|Genome Research|2014|425
Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy
|Molecular Cell|2017|282
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
|NeuroImage Clinical|2018|262
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
|Cancer Discovery|2022|137
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature
|European Radiology|2018|122